Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$1.02 - $3.8 $12,252 - $45,645
-12,012 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$3.26 - $4.66 $62,213 - $88,931
-19,084 Reduced 61.37%
12,012 $39,000
Q3 2021

Nov 01, 2021

BUY
$4.08 - $5.66 $126,871 - $176,003
31,096 New
31,096 $139,000
Q2 2021

Aug 12, 2021

SELL
$5.01 - $7.48 $82,715 - $123,494
-16,510 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$7.19 - $14.95 $118,706 - $246,824
16,510 New
16,510 $123,000
Q3 2020

Nov 09, 2020

SELL
$8.69 - $14.47 $196,602 - $327,369
-22,624 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$5.21 - $11.03 $45,597 - $96,534
8,752 Added 63.09%
22,624 $241,000
Q1 2020

Apr 30, 2020

BUY
$4.46 - $9.2 $61,869 - $127,622
13,872 New
13,872 $82,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.